Abbott, St. Jude Medical re-up ‘cardiovascular alliance’ | Wall Street Beat

April 23, 2012 By MassDevice staff Leave a Comment

Abbott (NYSE:ABT) and St. Jude Medical (NYSE:STJ) are renewing and expanding an alliance to co-market their cardiovascular products, including Abbott’s market-leading Xience coronary stent line.

The deal, which extends a pact the companies inked in 2008, also includes St. Jude’s line of cardiac rhythm management, electrophysiology and cardiology products.

Sign up to get our free newsletters delivered straight to your inbox

It will see Abbott and St. Jude jointly promote the other’s product offerings to U.S. hospital customers, according to a press release, and includes a separate agreement giving Abbott U.S. distribution rights for St. Jude’s hybrid Ilumien FFR/OCT platform and its RadiAnalyzer Xpress system.

Analyst: Thoratec, HeartWare to split the LVAD market
Thoratec (NSDQ:THOR) and HeartWare International (NSDQ:HTWR) are likely to carve out a 50-50 split of the market for left ventricular assist devices, at least for the next few years, according to "a high-volume EU cardiothoracic surgeon" from "1 of the largest LVAD implanting centers worldwide."

Leerink Swann analysts grilled the doc over the state of the LVAD market overseas, according to a research note to investors, coming away with 3 key points:

“International LVAD market growth is poised to continue at a sustainable low-to-mid-teens pace for the next few years"
"Thrombus concerns with HeartWare’s HVAD – which initially arose at last year’s ISHLT meeting – have eased significantly, at least amongst physicians"
"International competitive dynamics appear basically stable with major shifts in market share for THOR/HTWR seemingly unlikely in the near-term, in line with our basically 50%/50% split through 2015"

HTWR shares plunged after concerns over higher blood clot rates surfaced last year, but the physician interviewed by Leerink said the concerns came as a surprise to cardiac surgeons, prompting initial caution that quickly eased, according to the note.

"But after looking at data specific to his center, he found a 3.5% thrombus rate with HVAD – basically in line with the low-single-digit rate that Thoratec’s HeartMate II has historically generated. And he cited other centers with HVAD thrombus rates in the 3%-5% range, but ‘never exceeding 5%,’" the researchers wrote. "Still, he did also note that patient selection and post-operative patient management with HVAD played a meaningful role in driving that lower thrombus rate. With HVAD, patients at his practice receive heparin post-operation vs. none with HeartMate II."
Read more

Arrhythmia Research releases Q1 prelims
Arrhythmia Research Technology (NYSE:HRT) said it was unable to file its annual report with the SEC by its April 16 deadline "due to an ongoing internal review by the Audit Committee and auditors relating to the adjustments to the calculation of the tax deferred assets in the company’s Canadian subsidiary, RMDDx Corp.," according to a regulatory filing.

Arrhythmia Research said it expects to post preliminary revenues of $24.3 million and net losses of $1.7 million.
Read more

ETView Medical inks Taiwan distribution deal

ETView Medical (TLV:TLV) inked a 2-year distribution deal with Champ Medics Co. to market its VivaSight airway management platform in Taiwan.
Read more

DeHaier Medical in Chinese distribution deal with Timesco
Dehaier Medical Systems (NSDQ:DHRM) signed a 3-year distribution pact to sell Timesco of London’s Optima laryngoscope in China.
Read more

Nephros licences filtration tech from Medica
Nephros (OTC:NEPH) said it signed license & supply deal with Medica for exclusive global rights to sell the Italian company’s Medisulfone ultrafiltration technology.
Read more

Toshiba’s Vital Images inks MR deal with Olea
Toshiba Medical Systems‘ (TYO:6502) Vital Images subsidiary and Olea Medical are partnering to integrate thin-client advanced neurological MR solutions on Vital Image’s VitreaAdvanced enterprise visualization software.
Read more

SurgLine launches subsidiary to partner with spine surgeons
SurgLine Internationalsaid it’s formed SurgLine MDC Holdings LLC to pursue "cost containment of surgical implants in the operating room for hospitals and acute surgery centers," structured so that SMDC owns a minimum of 60% of each operating entity.
Read more

Funding Roundup

Analysts’ ups and downs

Abiomed (NSDQ:ABMD): Jefferies & Co. boosts price target from $25 to $28, maintains "buy" rating.
HeartWare International (NSDQ:HTWR): Zacks reiterates "neutral" rating, $70 price target.
Intuitive Surgical (NSDQ:ISRG): Barclays raises from "equal weight" to "overweight;" Zacks rates "#1 rank (strong buy)."
Kimberly-Clark (NYSE:KMB): Bank of America reiterates "buy" rating, raises price target from $80 to $84.

West Pharmaceutical Services appoints VP, GM of Asia Pacific
West Pharmaceutical Services this week announced it appointed Stewart Campbell as VP and general manager of the Asia Pacific region. Campbell will be responsible for the company’s Asia Pacific business and will lead region teams. “I am honored to serve West in this critical growth market, as it represents significant business opportunities that will ultimately… […]
Quest International increases breathing equipment services amid coronavirus pandemic
Quest International announced today that it is expanding its ISO 13485 service infrastructure in response to increased demand for ventilators and related medical devices during the COVID-19 pandemic. Irvine, Calif.-based Quest International shifted team members to focus on repairing and remediating ventilator devices, particularly in the depot and field service & logistics areas, according to… […]
Harting increases cable assembly supplies in response to COVID-19 pandemic
Harting Technology Group appears to be engaging in a fine balancing act: The Minden, Germany–based company says it is taking numerous measures to protect its employees, while also providing customer-specific cable assemblies for respiratory equipment and other medical devices needed to fight COVID-19. Several German manufacturers are currently producing the devices on which patients and… […]
FDA relaxes rules around ECMO devices during pandemic
The FDA has issued new guidance to help expand the availability of devices used in extracorporeal membrane oxygenation (ECMO) therapy to treat COVID-19 patients. Extracorporeal circuits and accessories for long-term respiratory/cardiopulmonary failure, including devices used for ECMO therapy, provide assisted extracorporeal circulation and physiologic gas exchange of a patient’s blood for more than 6 hours.… […]
Cantel Medical ups production of dental masks for COVID-19
Cantel Medical (NYSE:CMD) announced last week that it is increasing production of its surgical earloop dental mask amid the COVID-19 pandemic. The company is increasing manufacturing by its HuFriedyGroup dental division to 24 hours a day, seven days a week at its two New York manufacturing sites. The expectation is that production volume will increase by… […]
Carbon partners with Adidas, Resolution Medical on COVID-19 response
Carbon, the 3D printing company, announced today that it is working with Adidas on face shields for healthcare workers and with Resolution Medical on nasal swabs for COVID-19 testing. Adidas tweeted about its work with longtime collaborator Carbon, saying the athleticwear company is aiding Carbon’s production of face shields, which healthcare providers are using to… […]
German automotive supplier shifts production to face masks to battle COVID-19
Automotive supplier Wrapping Solutions (Rosengarten, Germany) is partnering with Optima Life Science to produce face masks to help fight the coronavirus pandemic. Wrapping Solutions specializes in producing interior fittings for cars — but has transitioned to sewing 24,000 masks per day at 20 workplaces since March 23. Over the long term, the company plans to… […]
Qosina touts single-use bioprocessing components for coronavirus response
With the bioprocess industry mobilizing to support the development of tests, vaccines and treatments for COVID-19, medtech distributor Qosina said that its supply of single-use bioprocessing components can offer significantly reduced time to clinic and market over multi-use systems during situations like the coronavirus pandemic. Ronkokoma, N.Y.-based Qosina said it also provides 3D CAD models… […]
Could these DIY ventilators stop coronavirus from killing people?
Amid the global crisis caused by the coronavirus pandemic, hospitals and healthcare facilities are reporting shortages of vital equipment that not only keeps the patients safe, but the staffers, too. One important device for which demand has ramped up is ventilators for patients who need assistance with their breathing due to the respiratory effects of… […]
How medtech manufacturers are bringing the fight to coronavirus
As the coronavirus pandemic spreads across the world, contract manufacturers and OEMs continue pivoting to meet the needs of front-line healthcare providers. Here are some of the latest examples: Stryker Stryker (NYSE:SYK) recently announced that it has developed a low-cost, limited-release emergency response bed for use in hospital emergency departments, triage and pop-up areas of… […]
DeviceTalks Weekly: Ep.4 — What does Medtronic’s Puritan reveal mean for medtech?
What does Medtronic’s Puritan reveal mean for medtech? Medtronic earned plaudits and praise for sharing the design specifications for its Puritan Bennett 560 (PB560) ventilators. But will the gesture actually lead to more ventilators being manufactured? In this episode of DeviceTalks Weekly, we’ll talk with experts who will tell us what the plans do and… […]